4.7 Article

Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation

Xueping Yang et al.

Summary: Celastrol has been shown to improve weight gain and metabolic disorders in obese mice by increasing adipose thermogenesis. Additionally, it reduces inflammatory cell infiltration and the expression of inflammatory cytokines, inhibiting the activation of TLR3/NLRP3 inflammasome molecules.

PHYTOTHERAPY RESEARCH (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Autophagy Mediates Leptin-Induced Migration and ERK Activation in Breast Cancer Cells

Alin Garcia-Miranda et al.

Summary: Autophagy is an intracellular recycling process that can be induced by leptin, a pro-tumorigenic protein, in cancer cell lines. Inhibition of autophagy reduces leptin-induced cell proliferation, migration, and ERK activation. This suggests a potential use for autophagy inhibition in breast cancer associated with obesity.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Immunology

The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer

Laura Garcia-Estevez et al.

Summary: Breast cancer interacts with adipose tissue, leptin, and the immune system in a complex way, with specific immune cells playing important roles in breast cancer.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Celastrol attenuates the inflammatory response by inhibiting IL-1β expression in triple-negative breast cancer cells

Daeun You et al.

Summary: In triple-negative breast cancer cells, the expression of IL-1β is decreased by celastrol, leading to reduced proliferation and invasiveness of cancer cells, as well as a decrease in the expression of IL-8 and matrix metalloproteinases.

ONCOLOGY REPORTS (2021)

Review Pharmacology & Pharmacy

Celastrol in metabolic diseases: Progress and application prospects

Shaohua Xu et al.

Summary: Celastrol, as an active ingredient derived from plants, has shown great potential in the treatment of metabolic diseases. Its anti-obesity effect is achieved through regulating various aspects, and it also shows effects on diseases like diabetes, atherosclerosis, and osteoporosis.

PHARMACOLOGICAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells

Prabhu Ramamoorthy et al.

Summary: The study showed that natural compounds celastrol and triptolide can inhibit cancer stem cells in TNBC and impact the Notch signaling pathway, potentially slowing down tumor progression.

BIOMEDICINES (2021)

Review Oncology

Tumour fatty acid metabolism in the context of therapy resistance and obesity

Andrew J. Hoy et al.

Summary: This review discusses the mechanistic links between fatty acid metabolism in cancer cells and disease behavior and therapy resistance, emphasizing the importance of factors such as lipid synthesis, storage, and catabolism in supporting tumorigenesis and treatment resistance. The role of membrane fatty acid composition is increasingly appreciated for promoting cell survival and limiting lipotoxicity and ferroptosis, while tumor cells exhibit plasticity in response to metabolic signals, such as obesity and cancer therapeutics, to promote aggressive, treatment-resistant disease. The study also highlights the impact of obesity-associated changes in host fatty acid metabolism on the tumor microenvironment and cancer cell behavior.

NATURE REVIEWS CANCER (2021)

Article Endocrinology & Metabolism

Effects of Microbiota on the Treatment of Obesity with the Natural Product Celastrol in Rats

Weiyue Hu et al.

DIABETES & METABOLISM JOURNAL (2020)

Article Cell & Tissue Engineering

RNA Sequencing of Human Peripheral Nerve in Response to Injury: Distinctive Analysis of the Nerve Repair Pathways

Andrew S. Welleford et al.

CELL TRANSPLANTATION (2020)

Article Oncology

Linkage Between Obesity Leptin and Breast Cancer

Manar Fayiz Atoum et al.

BREAST CANCER-BASIC AND CLINICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects

Xudong Feng et al.

NATURE MEDICINE (2019)

Review Oncology

The Impact of Obesity on Breast Cancer Diagnosis and Treatment

Kyuwan Lee et al.

CURRENT ONCOLOGY REPORTS (2019)

Article Multidisciplinary Sciences

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

Bingjun Sun et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Obesity and Breast Cancer: Role of Leptin

Flora Sanchez-Jimenez et al.

FRONTIERS IN ONCOLOGY (2019)

Review Medicine, Research & Experimental

Molecular modulators of celastrol as the keystones for its diverse pharmacological activities

Sin Wi Ng et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Biochemistry & Molecular Biology

Leptin is a direct transcriptional target of EGR1 in human breast cancer cells

JuHwan Kim et al.

MOLECULAR BIOLOGY REPORTS (2019)

Review Biochemistry & Molecular Biology

Computational Methods for Mapping, Assembly and Quantification for Coding and Non-coding Transcripts

Isaac A. Babarinde et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)

Review Oncology

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

Jake S. O'Donnell et al.

SEMINARS IN CANCER BIOLOGY (2018)

Review Oncology

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Adi J. Klil-Drori et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Medicine, Research & Experimental

Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer

Mohamed Hosney et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Article Pharmacology & Pharmacy

Leptin, obesity and breast cancer: progress to understanding the molecular connections

Ines Barone et al.

CURRENT OPINION IN PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Treatment of Obesity with Celastrol

Junli Liu et al.

Review Endocrinology & Metabolism

The multifactorial role of leptin in driving the breast cancer microenvironment

Sebastiano Ando et al.

NATURE REVIEWS ENDOCRINOLOGY (2012)

Article Oncology

Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells

Nadine A. Binai et al.

INTERNATIONAL JOURNAL OF CANCER (2010)